Get informed when a big investor buys or sells
+ FollowOvervalued by 388.7% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $95,800.00 |
|---|---|
| Enterprise Value | $3.39 Million |
| Earnings per Share | $-5064.66 |
| Beta | -1.78 |
| Outstanding Shares | 313,892 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.35 |
| Enterprise Value to EBIT | -0.25 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.03 |
| Debt to Equity | 0.19 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Shineco, Inc. develops and markets biological health products. The Company focuses on utilizing engineering technologies and biotechnologies to produce Chinese herbal medicines, organic agricultural produce, and specialized textiles.